[Guest post] Covid-19 Treatments: The Issue of Orphan Drug Status and Patents By Frantzeska Papadopoulou at Friday, April 03, 2020 COVID-19 EMA FDA Frantzeska Papadopoulou Guest post orphan drugs patents +
The right of the public to access documents v the right to confidentiality for marketing authorization (MA) documents: Transparency wins out in yesterday’s CJEU rulings By Frantzeska Papadopoulou at Thursday, January 23, 2020 access to documents EMA Frantzeska Papadopoulou MA marketing authorization presumption of confidentiality +
EMA relocation: and the winner is... By Eibhlin Vardy at Monday, November 20, 2017 Brexit EMA EMA relocation london Netherlands +
EMA/Commission guidance re centralised procedure and Brexit By Eibhlin Vardy at Monday, June 05, 2017 Brexit central MA Commission EMA marketing authorisation pharmacovigilance Q&A QPPV +